Allergic Reaction to Beta‐Glucans in an Obese Dog: A Case Report of Confirmed and Suspected Sources

Food allergy is defined as an abnormal immune system response to the ingestion of certain ingredients or food additives. Beta-glucans may support the management of obesity, particularly due to their immunomodulatory properties. However, the possible adverse reactions of this nutraceutical are little known. This report documents an allergic skin reaction in a 6-year-old obese mixed-breed dog after consuming 0.1% purified beta-1,3/1,6-glucans from Saccharomyces Cerevisiae and subsequent dermatological signs after ingesting beta-1,3-glucans from Euglena gracilis. The dog was enrolled in a clinical trial designed to evaluate the effects of two types of beta-glucans on digestive, immunological, and intestinal health in obese dogs. Three nutritionally similar extruded dry diets were utilized: a control (CTL) diet without beta-glucans, beta-glucan A (BGA) containing 0.1% beta-1,3/1,6-glucans, and beta-glucan B (BGB) with 0.1% beta-1,3-glucans. Initially, the dog was deemed healthy, with all clinical parameters being within normal ranges. After a 30-day adaptation period consuming the CTL diet, the dog was randomized to the BGA diet. Within 30 days, the owner reported intense pruritus, alopecia, and erythema in various areas. A nutritional consultation confirmed that the dog had never been exposed to beta-glucans before. The CTL diet was reinstated, resulting in symptom resolution within 1 week. Following a subsequent challenge with the BGA diet, dermatological manifestations reemerged after 14 days but again resolved after returning to the CTL diet. The owner then agreed to a challenge with the BGB diet, leading to the reappearance of clinical signs after 15 days. The CTL diet was reintroduced, resulting in symptom resolution within ten days. However, the owner declined further testing with the BGB diet. This case concludes that the dog exhibited allergic reactions to purified beta-1,3/1,6-glucans from Saccharomyces cerevisiae, while reactions to Euglena gracilis, although highly probable, remain unconfirmed due to the lack of a provocation test.

Authors

Institutions

Publication Details

Journal
Journal of Animal Physiology and Animal Nutrition
Published
2025-03-13
DOI
https://doi.org/10.1111/jpn.14111
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Allergic Reaction to Beta‐Glucans in an Obese Dog: A Case Report of Confirmed and Suspected Sources

Júlio César de Carvalho Balieiro, Rafael Vessecchi Amorim Zafalon, Andressa Rodrigues Amaral, Maria Terêsa Machini de Miranda et al.
Journal of Animal Physiology and Animal Nutrition
Dermatology and Skin Diseases
article

Allergic Reaction to Beta‐Glucans in an Obese Dog: A Case Report of Confirmed and Suspected Sources

Júlio César de Carvalho Balieiro, Rafael Vessecchi Amorim Zafalon, Andressa Rodrigues Amaral, Maria Terêsa Machini de Miranda, Leonardo de Andrade Príncipe, Thiago Henrique Annibale Vendramini, Pedro Henrique Marchi, Cinthia Gonçalves Lenz Cesar
article en

Abstract

Food allergy is defined as an abnormal immune system response to the ingestion of certain ingredients or food additives. Beta-glucans may support the management of obesity, particularly due to their immunomodulatory properties. However, the possible adverse reactions of this nutraceutical are little known. This report documents an allergic skin reaction in a 6-year-old obese mixed-breed dog after consuming 0.1% purified beta-1,3/1,6-glucans from Saccharomyces Cerevisiae and subsequent dermatological signs after ingesting beta-1,3-glucans from Euglena gracilis. The dog was enrolled in a clinical trial designed to evaluate the effects of two types of beta-glucans on digestive, immunological, and intestinal health in obese dogs. Three nutritionally similar extruded dry diets were utilized: a control (CTL) diet without beta-glucans, beta-glucan A (BGA) containing 0.1% beta-1,3/1,6-glucans, and beta-glucan B (BGB) with 0.1% beta-1,3-glucans. Initially, the dog was deemed healthy, with all clinical parameters being within normal ranges. After a 30-day adaptation period consuming the CTL diet, the dog was randomized to the BGA diet. Within 30 days, the owner reported intense pruritus, alopecia, and erythema in various areas. A nutritional consultation confirmed that the dog had never been exposed to beta-glucans before. The CTL diet was reinstated, resulting in symptom resolution within 1 week. Following a subsequent challenge with the BGA diet, dermatological manifestations reemerged after 14 days but again resolved after returning to the CTL diet. The owner then agreed to a challenge with the BGB diet, leading to the reappearance of clinical signs after 15 days. The CTL diet was reintroduced, resulting in symptom resolution within ten days. However, the owner declined further testing with the BGB diet. This case concludes that the dog exhibited allergic reactions to purified beta-1,3/1,6-glucans from Saccharomyces cerevisiae, while reactions to Euglena gracilis, although highly probable, remain unconfirmed due to the lack of a provocation test.

Journal of Animal Physiology and Animal Nutrition
Universidade de São Paulo (BR)
Zero hunger
Openalex Percentile: Top 90%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.